- Home
- EXEL vs MNYWW Comparison
EXEL vs MNYWW Comparison
Compare EXEL & MNYWW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EXEL
- MNYWW
- Stock Information
- Founded
- EXEL 1994
- MNYWW N/A
- Country
- EXEL United States
- MNYWW Singapore
- Employees
- EXEL N/A
- MNYWW 366
- Industry
- EXEL Biotechnology: Biological Products (No Diagnostic Substances)
- MNYWW
- Sector
- EXEL Health Care
- MNYWW
- Exchange
- EXEL Nasdaq
- MNYWW Nasdaq
- Market Cap
- EXEL 9.8B
- MNYWW N/A
- IPO Year
- EXEL 2000
- MNYWW N/A
- Fundamental
- Price
- EXEL $38.13
- MNYWW $0.04
- Analyst Decision
- EXEL Buy
- MNYWW
- Analyst Count
- EXEL 18
- MNYWW 0
- Target Price
- EXEL $37.59
- MNYWW N/A
- AVG Volume (30 Days)
- EXEL 2.4M
- MNYWW N/A
- Earning Date
- EXEL 05-02-2025
- MNYWW N/A
- Dividend Yield
- EXEL N/A
- MNYWW N/A
- EPS Growth
- EXEL 170.77
- MNYWW N/A
- EPS
- EXEL 1.76
- MNYWW N/A
- Revenue
- EXEL $2,168,701,000.00
- MNYWW N/A
- Revenue This Year
- EXEL $5.82
- MNYWW N/A
- Revenue Next Year
- EXEL $10.81
- MNYWW N/A
- P/E Ratio
- EXEL $21.27
- MNYWW N/A
- Revenue Growth
- EXEL 18.50
- MNYWW N/A
- 52 Week Low
- EXEL $20.14
- MNYWW N/A
- 52 Week High
- EXEL $40.02
- MNYWW N/A
- Technical
- Relative Strength Index (RSI)
- EXEL 57.87
- MNYWW 52.72
- Support Level
- EXEL $35.34
- MNYWW $0.03
- Resistance Level
- EXEL $37.67
- MNYWW $0.04
- Average True Range (ATR)
- EXEL 1.32
- MNYWW 0.00
- MACD
- EXEL 0.22
- MNYWW 0.00
- Stochastic Oscillator
- EXEL 95.46
- MNYWW 80.00
About EXEL Exelixis Inc.
Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.
About MNYWW MoneyHero Limited
MoneyHero Ltd is a personal finance aggregation and comparison company in Greater Southeast Asia. The firm is involved in the operation of online financial comparison platforms and related services for credit cards, personal loans, mortgages, insurance, and other financial products, connecting the providers of these products with well-matched and ready-to-transact consumers and generating revenue directly from these providers for placing their products on its platforms and providing insurance brokerage, marketing and events-related services.